HOME >> BIOLOGY >> NEWS
Acupuncture versus acid reflux: 40% cut in sphincter relaxations brings hope for relief

BETHESDA, Md. (August 30, 2005) Even the U.S. National Institutes of Health doesn't know what causes gastroesophageal reflux disease, or GERD. And NIH's National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) says there's an unclear relationship between GERD, heartburn and hiatal hernia (HH). Patients may have only one out of three, any two out of three, or all three.

Nevertheless, clinicians know that all three often occur together and that a variety of lifestyle changes, medication, surgery and recently approved devices and an implant are imperfect solutions.

An encounter between a Taiwanese gastroenterologist wanting to study acupuncture and an opening at the Royal Adelaide Hospital resulted in two experiments looking into how the traditional Eastern approach might affect transient lower esophageal sphincter relaxations (TLESRs). Since TLESRs are "the most important mechanism of acid reflux in normal subjects and patients with GERD," they were targeted for study.

The paper describing the study, "Inhibition of transient lower esophageal sphincter relaxations by electrical acupoint stimulation," appears in the August issue of the American Journal of Physiology-Gastrointestinal and Liver Physiology, published by the American Physiological Society. Research was performed by Duowu Zou, Wei Hao Chen, Katsuhiko Iwakiri, Rachael Rigda, Marcus Tippett and Richard H. Holloway of the Royal Adelaide Hospital, Australia.

The Neiguan connection

"It was an out-of-left-field approach, without any real expectations that it might work," according to Richard H. Holloway, in whose Royal Adelaide Hospital laboratory the work was done, "but we had well-defined technology and measurements for studying GERD." The protocol utilized electrical acupoint stimulation, a high-tech type of acupuncture, with a GERD model imposed on normal subjects by inflating a balloon in their stomachs.

In two separate studies, barely
'"/>


30-Aug-2005


Page: 1 2 3 4

Related biology news :

1. Prediction of graft-versus-host disease by gene-expression profiling of donors and more
2. Preventing graft-versus-host disease disease after bone marrow transplant -- without toxicity
3. Risk/benefit analysis of farmed versus wild salmon
4. Sex versus survival: A tradeoff at geographical range limits
5. Coke versus Pepsi: Its all in the head
6. MIT study: Maturity brings richer memories
7. Variant CJD -- Prion amplification breakthrough brings new insights and hopes for a blood test
8. Extracting eggs from pre-pubertal cancer patients brings hope for future fertility
9. Dilbert of academia brings humor to talk at UH
10. Disorderly protein brings order to cell division
11. $1 million Myers Fellowship brings US research techniques to Melbourne

Post Your Comments:
(Date:11/4/2014)... Nov. 4, 2014   Neurotechnology , a ... that the latest version of its fingerprint matching ... Ongoing MINEX evaluation organized by NIST. The ... using the INCITS 378 fingerprint standard template format. ... public tenders in the United States ...
(Date:11/3/2014)... study published in this month,s Proceedings of ... of a recently discovered communication molecule of the body,s ... known to limit inflammation and the current study reports ... the ability of the immune system to recognize and ... IL-37,s effect on the immune system now allows us ...
(Date:11/3/2014)... that low birth weight and preterm birth are linked ... adulthood. Findings published in the American College of Rheumatology ... that low birth weight and pre-term babies were not ... as adults. , According to the ACR, 27 ... with clinical OA. Symptoms of OA range from mild ...
Breaking Biology News(10 mins):Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 2Neurotechnology Places Second in Ongoing MINEX Ranking for Fingerprint Matching Algorithms 3PNAS: From HIV to cancer, IL-37 regulates immune system 2Preterm, low birth-weight babies may need new hips in adulthood 2
(Date:11/21/2014)... 2014 , Todd Martensen ... Mariano Rodríguez es elegid vicepresidente senior de desarrollo ... está en marcha para comenzar de forma rápida la comercialización ... reciente aprobación en Europa   , ... anunciar los siguientes nombramientos: Todd Martensen ...
(Date:11/21/2014)... 2014 Author Matthew J. Pallamary’s second ... Other Side” published as a tribute to his ... “Fiction: Short Story” category of the 2014 USA ... CEO of USA Book News, said this year’s contest ... including Simon & Schuster, Penguin, John Wiley & Sons, ...
(Date:11/21/2014)... 20, 2014 BlueInGreen, LLC ( ... LLC (Pinnacle), and PCI, Inc., leading suppliers of ... have been selected to provide a new state-of-the-art ... Paul R. Noland Wastewater Treatment. The new ... HyDOZ® gas dissolution technology, Pinnacle Ozone’s industry ...
(Date:11/21/2014)... Nov. 20, 2014 Polaris Group announced ... in its Phase 1 trial of ADI-PEG 20 ... treatment of malignant pleural mesothelioma (MPM) and non-squamous ... clinical trials on ADI-PEG 20, both as monotherapy ... treatment of several other indications, including breast cancer, ...
Breaking Biology Technology:KLOX Technologies anuncia sus nombramientos ejecutivos 2KLOX Technologies anuncia sus nombramientos ejecutivos 3KLOX Technologies anuncia sus nombramientos ejecutivos 4KLOX Technologies anuncia sus nombramientos ejecutivos 5Mystic Ink 's Short Story Collection “A Short Walk to the Other Side” Honoring Ray Bradbury Praised As Award-Winning Finalist In USA Best Book Awards 2Mystic Ink 's Short Story Collection “A Short Walk to the Other Side” Honoring Ray Bradbury Praised As Award-Winning Finalist In USA Best Book Awards 3Mystic Ink 's Short Story Collection “A Short Walk to the Other Side” Honoring Ray Bradbury Praised As Award-Winning Finalist In USA Best Book Awards 4City of Fayetteville Leads Nation with Innovative Ozone Technology 2City of Fayetteville Leads Nation with Innovative Ozone Technology 3City of Fayetteville Leads Nation with Innovative Ozone Technology 4Polaris Group Announces Treatment of First Patient in Phase 1 Study of ADI-PEG 20 plus Pemetrexed and Cisplatin in Malignant Pleural Mesothelioma And Non-Squamous Non-Small Cell Lung Carcinoma 2
Cached News: